WO2000073414A1 - Bacteria transformation kit - Google Patents

Bacteria transformation kit Download PDF

Info

Publication number
WO2000073414A1
WO2000073414A1 PCT/TR2000/000027 TR0000027W WO0073414A1 WO 2000073414 A1 WO2000073414 A1 WO 2000073414A1 TR 0000027 W TR0000027 W TR 0000027W WO 0073414 A1 WO0073414 A1 WO 0073414A1
Authority
WO
WIPO (PCT)
Prior art keywords
bacteria
transformation
bsa
cacl
rapid
Prior art date
Application number
PCT/TR2000/000027
Other languages
French (fr)
Inventor
Tanil KOCAGÖZ
Filiz Öner
Devrim Demir
Original Assignee
Kocagoez Tanil
Oener Filiz
Devrim Demir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kocagoez Tanil, Oener Filiz, Devrim Demir filed Critical Kocagoez Tanil
Priority to AU47950/00A priority Critical patent/AU4795000A/en
Publication of WO2000073414A1 publication Critical patent/WO2000073414A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04Preserving or maintaining viable microorganisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Definitions

  • This invention is related with a product or a method to be used in bacterial transformation for molecular cloning and other purposes
  • the area of method and product is related with microbiology, recombinant DNA technology and pharmaceutical biotechnology, but the method and the product have no connection with the methods being used in the diagnosis and treatment of diseases
  • DNN intended to be put into the cell is placed in a cuvette together with host cell suspension, between two electrodes and an electrical current is applied Usually 250 ⁇ F current is applied every 4 seconds Some parts of cytoplasmic membrane is subjected to a reversible breakdown when a strong current is applied for a brief period of time, and D ⁇ A molecules enter the cells Method is rapid and applicable for every cell type but it is expensive and if the application period of current is not optimized properly, host cells die and lowers the number of surviving bacteria
  • Bacterial transformation kit has the advantages of providing materials and a practical method to transform bacteria by plasmids, within 45 minutes
  • Bacteria transformation kit is a product that provides the materials and the method needed for rapid and easy transformation of bacteria, which is widely used as a main step in recombinant DNA technology and many other research procedures related to molecular biology By using currently available conventional methods, procedures can either be completed in a few days or expensive equipment are required for the rapid ones
  • Bacteria transformation kit provides an easy and rapid transformation method and materials without necessitating specific apparatus or detailed procedures. Fundamental principle and innovation of the method is based on use of a cationic lipid- surfactant system to carry the plasmid DNA into bacteria and a specific washing procedure using bovine serum albumin (BSA) These type of systems are started to be used widely in mammalian cells but effectiveness of the systems on bacteria or yeast cells have not been investigated yet. Bacteria transformation kit can deliver the plasmids into bacteria in a very short time period without giving harmful effect and bacterial transformation can be achieved with high yield and reproducibility
  • BSA bovine serum albumin
  • Bacteria transformation kit is composed of 3 solutions which are A, B and M solutions
  • Solution A contains 50 mM CaCl 2.
  • solution B contains 5% m/v BSA (Bovine Serum Albumine) and solution M contains 1.25 % v/v (N(l-(2,3-dioleyloxy)propyl)-N,N,N, trimethyl ammonium bromide) / (dioleoylphosphatidylethanolamine) (DOTAP/DOPE) and

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Transformation is an important step in DNA cloning, which is one of the most important component of recombinant DNA technology and many other areas of molecular biology. Bacteria transformation kit provides an easy way to transform bacteria by plasmids in a short period of time by the formulation prepared with lipid-plasmid complexes and the method mentioned below.

Description

BACTERIA TRANSFORMATION KIT
DESCRIPTION OF THE INVENTION
Technical Area Related with Invention: This invention is related with a product or a method to be used in bacterial transformation for molecular cloning and other purposes The area of method and product is related with microbiology, recombinant DNA technology and pharmaceutical biotechnology, but the method and the product have no connection with the methods being used in the diagnosis and treatment of diseases
Transformation of foreign genetic materials into cells by lipids has become a common technique for mammalian cell systems But transformation efficiency of these carriers for bacteria and yeast cells haven't been investigated yet Previous Techniques: Electroporation and methods requiring the preparation of competent bacteria, are widely used for bacterial transformation Electroporation requires expensive equipment and the optimization of the method is difficult Results obtained from one experiment is not usually reproducible
In electroporation, DNN intended to be put into the cell, is placed in a cuvette together with host cell suspension, between two electrodes and an electrical current is applied Usually 250 μF current is applied every 4 seconds Some parts of cytoplasmic membrane is subjected to a reversible breakdown when a strong current is applied for a brief period of time, and DΝA molecules enter the cells Method is rapid and applicable for every cell type but it is expensive and if the application period of current is not optimized properly, host cells die and lowers the number of surviving bacteria
Methods requiring the preparation of competent bacteria, are difficult and time consuming Due to this reason, most of the investigators are purchasing marketed ready- made competent bacteria stored and shipped as frozen, but stability and finance problems are encountered here Methods used for preparing competent bacteria, need at least one night incubation Method is as follows
1 Inoculate bacteria in a 50 ml tube containing 15 ml Luria-Bertani (LB) broth growth medium
2 Incubate overnigh at 37°C preferentially by shaking
3 Inoculate 50 μl of the overnight culture into 15 ml of fresh LB broth 4 Incubate for 2 hours at 37°C After incubation, centrifuge the tube to obtain bacterial pellet 5 Discard the supernatant, resuspend the pellet in 1 5 ml cold CaCl2 solution and incubate on ice for one hour 6 Centrifuge to pellet the cells and discard the supernatant
7 Resuspend the pellet in 1 5 ml cold CaCl2 solution again and incubate overnight at 4°C
8 After overnight incubation add your plasmid to 200μl of competent bacteria and place the tube 35 minutes on ice, 1 5 minutes on 42°C water bath and again 10 minutes on ice
9 Add 1ml of LB broth to the transformed bacteria and incubate at 37°C for one hour
10 Inoculate bacteria to the appropriate selective medium and continue incubation at 37°C until the colonies become visible
As can be seen from the descriptions above, classical methods either require several days for preparation or expensive equipment like electroporators They are either long and cumbersome or harmful to bacteria due to electrical current used Bacterial transformation kit has the advantages of providing materials and a practical method to transform bacteria by plasmids, within 45 minutes
Objectives of the Invention Subject
1 To develop a very economical rapid method instead of a conventional procedure which requires expensive equipment
2 To shorten a 2-3 days long conventional experimental procedure to a very short period of time such as 15-60 minutes
3 To speed up biotechnological procedures by speeding transformation, a main step for molecular cloning and provide a time-based profit
4 To simplify multistep and difficult procedures into a practical, rapid method
5 To develop a highly reproducible and efficient method of transformation instead of low reproducible conventional methods
6 To develop a product for providing the materials needed for the easy transformation protocol
Explanation of the Invention Subject Bacteria transformation kit is a product that provides the materials and the method needed for rapid and easy transformation of bacteria, which is widely used as a main step in recombinant DNA technology and many other research procedures related to molecular biology By using currently available conventional methods, procedures can either be completed in a few days or expensive equipment are required for the rapid ones
Furthermore, reproducability and yield can not be reached every time as desired. Bacteria transformation kit provides an easy and rapid transformation method and materials without necessitating specific apparatus or detailed procedures. Fundamental principle and innovation of the method is based on use of a cationic lipid- surfactant system to carry the plasmid DNA into bacteria and a specific washing procedure using bovine serum albumin (BSA) These type of systems are started to be used widely in mammalian cells but effectiveness of the systems on bacteria or yeast cells have not been investigated yet. Bacteria transformation kit can deliver the plasmids into bacteria in a very short time period without giving harmful effect and bacterial transformation can be achieved with high yield and reproducibility
Bacteria transformation kit is composed of 3 solutions which are A, B and M solutions
Solution A contains 50 mM CaCl2. solution B contains 5% m/v BSA (Bovine Serum Albumine) and solution M contains 1.25 % v/v (N(l-(2,3-dioleyloxy)propyl)-N,N,N, trimethyl ammonium bromide) / (dioleoylphosphatidylethanolamine) (DOTAP/DOPE) and
0.05 % m/v zwitterionic surfactant with 8 carbons. Procedure of bacteria transformation by using bacteria transformation kit is as follows
1 Prepare a culture of bacteria in a 50 ml tube containing 15 ml Luria-Bertani (LB) broth or another appropriate growth media Incubate overnigh at 37°C preferentially by shaking
2. Inoculate 300 μl of the overnight culture into 15 ml of fresh LB broth After incubation at 37°C for 2 hours centrifuge culture media to obtain bacterial pellet
3 Resuspend the pellet in 1 ml cold solution A (50 mM CaCl2 ) and vortex to suspend Centrifuge and discard the supernatant
4 Resuspend the pellet in 200 μl solution A (50 mM CaCl2 ) Add 0 1-10 μg plasmid with or without solution M after mixing at 1/5-1/2 v/v ratio at a volume of 1-20 μl Place the tube consequently 15 minutes on ice, 1 5 minutes on 42°C water bath, and 3 minutes on ice 5 Centrifuge mixture to obtain bacterial pellet and discard the supernatant Add 500 μl solution B (5 % m/v BSA), mix by vortexing, centrifuge to obtain bacterial pellet and discard the supernatant 6 Resuspend the pellet in 200-300 μl LB broth by vortexing 7 By using one plate for each 50-100 μl of transformed bacterial suspension, inoculate bacteria to selective medium
Number of transformant bacteria is incread after washing with BSA This result is probably related with removal of the toxic products from media, which are harmful for bacteria Method can be carried out either with fresh or overnight grown bacteria, but higher transformation efficiency is obtained with fresh bacteria Transformation efficiency is increased further by incubating bacteria with lipid complexes

Claims

1. Use of 5 % m/v BSA as a washing solution to increase bacterial transformation and survival.
2. Use of lipids like 1.25 % v/v (N(l-(2,3-dioleyloxy)propyl)-N,N,N, trimethyl ammonium bromide) / (dioleoylphosphatidylethanolamine) (DOTAP/DOPE) mixture and surfactants like 0.05 % m/v zwitterionic surfactant with 8 carbons for increasing bacterial transformation efficiency.
3. A transformation kit containing 50 mM CaCl2 and 5 % m/v BSA solutions for transforming easy and rapid transformation of bacteria.
4. A seperate kit containing 50 mM CaCl2 and 5 % m/v BSA and 1.25 % v/v (N(l-(2,3- dioleyloxy)propyl)-N,N,N, trimethyl ammonium bromide) / (dioleoylphosphatidyl- ethanolamine) (DOTAP/DOPE) and 0.05 % m/v zwitterionic surfactant with 8 carbons together with the solutions mentioned in the 3rd claim.
5. Easy and rapid transformation method provided with the kits mentioned in the 3rd and 4th claims.
6. Use of the kits mentioned in claims 3 and 4 for the transformation of foreign genetic material to yeasts.
PCT/TR2000/000027 1999-05-31 2000-05-25 Bacteria transformation kit WO2000073414A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU47950/00A AU4795000A (en) 1999-05-31 2000-05-25 Bacteria transformation kit

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR99/01199 1999-05-31
TR1999/01199A TR199901199A2 (en) 1999-05-31 1999-05-31 Bacterial transformation kit

Publications (1)

Publication Number Publication Date
WO2000073414A1 true WO2000073414A1 (en) 2000-12-07

Family

ID=21621999

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2000/000027 WO2000073414A1 (en) 1999-05-31 2000-05-25 Bacteria transformation kit

Country Status (3)

Country Link
AU (1) AU4795000A (en)
TR (1) TR199901199A2 (en)
WO (1) WO2000073414A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2383582A (en) * 2001-11-09 2003-07-02 Yeastern Biotech Co Ltd Method of transforming competent cells
WO2005061717A1 (en) * 2003-12-19 2005-07-07 Dainippon Sumitomo Pharma Co., Ltd. Novel method of nucleic acid transfer
US8742091B2 (en) 2001-06-20 2014-06-03 Dainippon Sumitomo Pharma Co., Ltd. Method of promoting nucleic acid transfer

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703055A (en) * 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
WO1998007408A1 (en) * 1996-08-19 1998-02-26 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Novel liposome complexes for increased systemic delivery

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703055A (en) * 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
WO1998007408A1 (en) * 1996-08-19 1998-02-26 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Novel liposome complexes for increased systemic delivery

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8742091B2 (en) 2001-06-20 2014-06-03 Dainippon Sumitomo Pharma Co., Ltd. Method of promoting nucleic acid transfer
GB2383582A (en) * 2001-11-09 2003-07-02 Yeastern Biotech Co Ltd Method of transforming competent cells
GB2383582B (en) * 2001-11-09 2005-02-23 Yeastern Biotech Co Ltd A method of transforming competent cells
US6864088B2 (en) 2001-11-09 2005-03-08 Yeastern Biotech Co., Ltd. Fast method of transforming competent cells
DE10251429B4 (en) * 2001-11-09 2008-08-21 Yeastern Biotech Co., Ltd. A fast method for transforming competent cells
WO2005061717A1 (en) * 2003-12-19 2005-07-07 Dainippon Sumitomo Pharma Co., Ltd. Novel method of nucleic acid transfer

Also Published As

Publication number Publication date
AU4795000A (en) 2000-12-18
TR199901199A3 (en) 2001-09-21
TR199901199A2 (en) 2001-09-21

Similar Documents

Publication Publication Date Title
Crooke et al. ProOmpA is stabilized for membrane translocation by either purified E. coli trigger factor or canine signal recognition particle
KR100546009B1 (en) Preparation containing cell extracts for cell-free protein synthesis and means for synthesizing cell-free protein
AU2004272748B2 (en) Method of preparation of pharmaceutically grade plasmid DNA
IL268868A (en) Novel method of protein purification
Schleef et al. Production of non viral DNA vectors
JPH10508203A (en) Method of producing heterologous polypeptide having disulfide bond by bacteria
JPH05500304A (en) A method of introducing molecules, especially genetic material, into plant cells
EP0811055B1 (en) Method for lysing cells
CN111448315B (en) Method for separating DNA by Cas protein system
WO2000073414A1 (en) Bacteria transformation kit
JP4372421B2 (en) Methods and compositions for extracting proteins from cells
Sørhaug et al. Fractionation of dipeptidase activities of Streptococcus lactis and dipeptidase specificity of some lactic acid bacteria
Li et al. Delivery of a PCR amplified DNA fragment into cells: a model for using synthetic genes for gene therapy
EP0254315B1 (en) Mammalian cell derived autonomously replicating sequence DNA fragments having affinity to DNA binding proteins
CN112824530A (en) HEK293F suspension cell high-efficiency electrotransfection method
JPH09508024A (en) Extraction of heterologous insoluble proteins from bacteria
EP0666924A1 (en) Particle transfection: a method for the transfer of polynucleotide molecule into cells
Rodriguez et al. NADH-activated cell-free transfer between Golgi apparatus and plasma membranes of rat liver
Minas et al. Co-overexpression of prlF increases cell viability and enzyme yields in recombinant Escherichia coli expressing Bacillus stearothermophilus. alpha.-amylase
JPS58501406A (en) Increased expression of protein synthesis in Escherichia coli
JPH0235083A (en) Dna having genetic information of lipase
JPS63141579A (en) Method for controlling cultivation in high efficiency
Kaminskas Cell-serum factor interaction: Characteristics of stimulation of protein synthesis in Ehrlich ascites cells by factors in serum and in cell extracts
JPH0530967A (en) Production of human-lysozyme
CN118028326A (en) Cell-free reaction system of anaerobic enzyme and expression method

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP